Clinical and epidemiological studies support a connection between obesity and thrombosis,
involving elevated expression of the prothrombotic molecules plasminogen activator …

Plasma free fatty acid (FFA) levels are elevated in obesity. FFAs cause insulin resistance in
all major insulin target organs (skeletal muscle, liver, endothelial cells) and have emerged …

Diabetes mellitus is characterized by a high risk of atherothrombotic events. What is more,
venous thrombosis has also been found to occur more frequently in this patient group. This …

The existence of an independent association between elevated triglyceride (TG) levels,
cardiovascular (CV) risk and mortality has been largely controversial. The main difficulty in …

Atherothrombosis is the leading cause of morbidity and mortality in patients with diabetes
mellitus. Several mechanisms contribute to the diabetic prothrombotic state, including …

Atherothrombotic complications are the main cause of mortality in subjects with diabetes.
Premature atherosclerosis, increased platelet reactivity and activation of coagulation factors …

Obesity is associated with an increased incidence of insulin resistance (IR), type 2 diabetes
mellitus and cardiovascular diseases. The increased risk for cardiovascular diseases could …

An enhanced thrombotic environment and premature atherosclerosis are key factors for the
increased cardiovascular risk in diabetes. The occlusive vascular thrombus, formed …

Because of its high prevalence and potential to alter critical elements of sepsis
pathophysiology, diabetes is likely an important comorbid condition in this disease; yet the …

Patients with diabetes mellitus are at increased risk of cardiovascular morbidity and
mortality. Atherothrombosis, defined as atherosclerotic lesion disruption with superimposed …